CLI Research Pinpoints Actions to Reduce Contact Lens Dropout
Myopia Action Month Returns, Uniting ECPs Worldwide this September
CLI Teams with Football Broadcaster Gene Steratore for Healthy Contact Lens Wear
New CORE Publication Provides Guidance on Cosmetics and Ocular Health
Myopia Profile Launches 'Made Simple' Courses to Empower ECPs with Practical Myopia Management
CooperVision Leads Myopia Control Dialogue: Bridging Optometry and Ophthalmology
Second Annual Myopia Action Month Set for September 2024
Latest CORE Publication Offers Soft Toric Contact Lens Insights for Practitioners
Avalue to Showcase Cutting-edge Smart Healthcare Solutions at Japan's International Modern Hospital Show 2024
Overcoming Children’s Eye Health Obstacles @ IAPB’s 2030 In Sight Live
-
World Council of Optometry and Alcon Extend Global Partnership for Dry Eye Disease Education
The World Council of Optometry (WCO) and Alcon are extending their education initiative to advance global, evidence-based dry eye disease education, which has garnered widespread exposure and interest over the past two years. Dry eye disease is a chronic, painful condition that impacts 1.4 billion people worldwide,[1] with reports of increased occurrence aligning with notable factors such as increasing use of technology, environmental triggers, and an aging population.[2] As part of the renewed collaboration, an update to the existing WCO Alcon Dry Eye Wheel is now available. This practical tool is designed to raise optometrists’ understanding of dry eye disease diagnosis and practical management. Now expanded to include content surrounding diet / dietary supplements, in-office and complex treatments, the latest version provides multifaceted, evidence-based knowledge that can be used in nearly all eye care environments. A dedicated website at dryeye.worldcouncilofoptometry.info includes a series of dry eye webinars recorded with world-renowned opinion leaders and also provides a robust collection of resources that can be used in clinical and educational settings. WCO President Sandra Block, O.D., M. Ed., MPH, FAAO, FCOV, said, “Extending our partnership with Alcon supports the education of optometrists globally about practical measures to better address dry eye, a condition that, without proper diagnosis and treatment, can lead to ocular surface disease. This year, we are planning more collaboration with university educators to increase access to the WCO Alcon Dry Eye Wheel and related educational resources for future generations of eye care professionals.” “We are all becoming more aware of the growing incidence and impact of dry eye on our patients. Within the last year, we have seen publications further clarifying some of the issues contributing to this rise¾from digital device use to social and environmental factors,” said Carla Mack, OD, MBA, FAAO, FBCLA, Head, Global and U.S. Professional Education and Development for Alcon. “We are proud to extend our ongoing partnership with the World Council of Optometry, reinforcing our commitment to helping make dry eye more understandable for both eye care professionals and patients. The ultimate goal is to empower optometrists to engage in conversations about this multi-factorial condition and educate on management options for their patients experiencing dry eye symptoms.” More information on the updated version of the WCO Alcon Dry Eye Wheel and other activities planned for the second year of the partnership will be posted to www.worldcouncilofoptometry.info and to the initiative’s dedicated website at dryeye.worldcouncilofoptometry.info ### [1] MarketScope (2020) 2020 Dry Eye Products Market Report. A Global Analysis for 2019 to 2025. October 2020. [2] Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K et al. (2017) TFOS DEWS II Epidemiology Report. Ocul Surf 15 (3): 334-365.
-
SightGlass Vision DOT Data Affirms Myopia Management Performance
Myopia management innovator SightGlass Vision will present new data surrounding its Diffusion Optics Technology™ (DOT 0.2) spectacle lenses from four studies at the ARVO 2024 Annual Meeting, which will draw thousands of eye and vision scientists to Seattle from May 5-9. The collective scientific body of knowledge deepens support for DOT™ spectacle lenses’ efficacy, safety, mechanism of action, and positive patient experience. The company’s flagship myopia control intervention uses thousands of light scattering elements to mimic more natural contrast on the retina—a unique mechanism of action to slow myopia progression in children. Building on its long-term CYPRESS trial, SightGlass Vision initiated CATHAY—a two-year, randomized, controlled clinical trial of children ages 6 to 13 across five sites in China. Control of Myopia Using Diffusion Optics Technology (DOT) Spectacle Lenses in a Chinese Population (Laughton D, et al) analyzes 71 participants at the six-month mark, indicating that DOT lenses substantially slowed myopia progression, as measured by cycloplegic spherical equivalent refraction (cSER) and axial length (AL), compared to the standard single vision spectacle lens control group. AL increased from baseline by 0.19 mm (p <0.001) in the control compared to -0.05 mm (p=0.04) among DOT lens wearers. cSER increased from baseline by -0.38D (p<0.0001) among the control versus by 0.01D (p=0.85) with the DOT group. Unadjusted mean differences in the changes from baseline were significant: -0.23 mm for AL and 0.39D for cSER. “The CATHAY interim results further validate the findings from our multi-year CYPRESS study, supporting the hypothesis that modulating retinal contrast can slow myopia progression in children from diverse populations,” said Debbie Laughton, BSc, PhD, Director of Medical Affairs for SightGlass Vision. Short Term Effect of DOT Spectacle Lenses on Choroidal Thickness in Emmetropic Children (Jabeen A, et al) illustrates the macula choroidal thickening (ChT) in children following short-term DOT spectacle lens wear, similar or greater to response from +3.00D spectacle lens use—a positive indication that contrast reduction favorably affects this uveal tract tissue. Conducted by the Centre for Ocular Research & Education (CORE), the research enrolled 30 children ages 8 to 14 in a two-visit, prospective, randomized, subject-masked crossover study. Treatment Zone Visual Acuity with Myopia Control Spectacle Lenses (Rani R, et al) profiles the immediate effect of Diffusion Optics Technology (DOT), Defocus Incorporated Multiple Segments (DIMS), and Highly Aspherical Lenslets (HAL) interventions on high- and low-contrast foveal visual acuity (VA). Investigators from Aston University’s Optometry & Vision Science Research Group enrolled 20 myopia adults in the prospective, single-visit, double-blind, four-way randomized crossover study to compare the technologies to single vision plano spectacle lenses. All three myopia management technologies performed well against the single vision lens, with DOT lenses providing superior VA in the peripheral treatment zone. Aston researchers are also presenting findings from The Short-Term Effects of Spectacle-Based Myopia Management Interventions on Dynamic Vision (Davis L, et al), which used the same group of participants. Dynamic vision when wearing DOT, DIMS, or HAL spectacle lenses was noted as good and generally similar to the single vision control. “Our scientific program at ARVO 2024 adds to the substantial evidence supporting the myopia control efficacy of Diffusion Optics Technology, as well as guiding eye care professionals on making more informed choices regarding spectacle lens interventions. We are enthusiastic about how DOT lenses have been received in multiple countries and remain excited by the prospect of reaching even more children around the world,” said Andrew Sedgwick, CEO of SightGlass Vision. SightGlass Vision’s patent-protected technology with clinically proven efficacy[1],[2],[3],[4] has made its commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. The company operates as a joint venture of CooperCompanies and EssilorLuxottica. For more information, visit SightGlassVision.com ### [1] Chalberg T., et al. Control of Myopia Using Diffusion Optics Spectacle Lenses: Efficacy and Safety Study (CYPRESS) 42-month results. ARVO 2023 Annual Meeting presentation. 27 April 2023. [2] Control of myopia using Diffusion Optics Technology™ spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). British Journal of Ophthalmology Published Online First: 01 September 2022. DOI: 10.1136/bjo-2021-321005 [3] Rappon J., et al. Two-year effectiveness of a novel myopia management spectacle lens with full-time WEARERS. Invest. Ophthalmol. Vis. Sci. 2022;63(7):408. [4] Laughton, D et al. Safety and Efficacy of a Novel Spectacle Lens for Myopia Control Over Three Years. 2022 American Academy of Optometry annual meeting. 27 Oct 2022.
-
CLI Report Highlights Ways to Attract Potential & Former Contact Lens Patients
The Contact Lens Institute (CLI) has published an in-depth report on everyday actions that the eye care community can take to draw interest from potential and former contact lens wearers. Based on research with more than 1,000 vision-corrected adults segmented by glasses-only wearers, new contact lens wearers, and contact lens dropouts, “Beyond Vision: Behaviors to Attract New & Returning Contact Lens Wearers” is the latest offering from CLI’s See Tomorrow initiative, which helps practices thrive using exclusive consumer data and insights. The 26-page document includes multiple infographics depicting high value takeaways, which are ideal for staff training. Another 19 quick take columns and bulleted checklists offer practical implementation tips, all of which were contributed by 2024 CLI Visionaries. The report is available for download or online reading at https://www.contactlensinstitute.org/resources/see-tomorrow/. “With 47.8% of glasses wearers indicating a high interest in trying contact lenses, and lapsed contact lens wearers signaling what would motivate them to resume use, the tremendous untapped potential for the category is unmistakable,” said Stan Rogaski, CLI’s executive director. “Our research found specific areas of consumer excitement, concern, and misperception that eye care practices can leverage to aid more efficient and effective contact lens conversations among likely candidates. Better yet, these aspects can be reinforced easily and quickly across the entire patient experience, from appointment scheduling to the exam to follow-up, by every member of the practice team.” Highlights explored within the “Beyond Vision” report include: Sources of contact lens influence, led by optometrists and ophthalmologists (66% of glasses wearers / 46% of new contact lens wearers), opticians (44% of glasses wearers / 26% of new contact lens wearers), and friends and family (40% of glasses wearers, 31% of new contact lens wearers). A ranking of 25 factors that would aid potential wearers’ consideration of contacts, with an eye doctor explaining why contacts can benefit a patient placing first (66%). Other aspects that practice teams may take for granted were also evident, such as understanding insertion and removal (52%), taking trial lenses home (51%), and knowing about the range of price and performance options (47%). Primary motivators for initial contact lens trial among new wearers, who called out freedom from glasses (44%), personal appearance (42%), and ease of use (39%) as the most significant. A review of which contact lens advancements spark the most excitement, with toric designs (46%) and UV protection (43%) cited most by potential wearers, and contacts for digital device use and UV protection tied for the highest spot (64%) by new contact lens wearers. Practice behaviors that detract from contact lens trial, including a lack of exam staff raising the subject, not alerting patients they were candidates, and not providing contact lens information—all cited by about 20% of glasses-only respondents. Additional non-behavioral issues that dissuade trial, including fear factors such as patients not wanting to touch their eye (44%) and infection concerns (25%); affordability (30%); and misperceptions that having dry eye (27%) and astigmatism (17%) prevent contact lens wear—most of which can be addressed through communication. Ratings from former contact lens wearers of what would motivate them to return, split by those who dropped out within the past two years compared to longer-term dropouts. Among more recent dropouts, awareness of new advances (55%), a renewed conversation with their eye doctor about contact lens benefits (50%), dual/part-time wear alongside glasses (50%), and the availability of trial lenses (50%) were at the top. Those who abandoned wear longer ago placed the most weight on being made aware of contact lenses for a specific eye condition (85%), of new advances and technologies (74%), price and performance options (72%) and access to trial lenses (66%). The additive value of having contact lens advocates throughout the practice, as up to 30% of glasses-only wearers reported that such enthusiasm would influence their decision to try contacts. When it comes to discussing the benefits of contact lenses, the research outcomes emphasized the importance of doctors personally having that conversation, versus fully delegating information sharing to their teams. For glasses wearers, the recommendation from the optometrist or ophthalmologist matters to 66% of them, compared to 22% for eye exam staff and 8% for eyewear display staff. 2024 CLI Visionaries who contributed to “Beyond Vision” are Monica Bhula, OD; Shelby Brogdon, OD; Andrew S. Bruce, LDO, ABOM, NCLEM, FCLSA; Jenn Seymour Brusven, LDO, NCLE-AC, ABO-AC, AAS; Ariel Cerenzie, OD, FAAO, FSLS; Angelica Cifuentes, OD; Jade Coats, OD; Jason Compton, OD, FAAO; Janelle Davison, OD; Sabrina Gaan, OD; Lisa Hornick, OD, MBA, FAAO; Diana Mejia; Scott Moscow, OD; Ashley O’Dwyer, OD; Shalu Pal, OD, FAAO, FSLS, FBCLA, FIAOMC; Adam Ramsey, OD; Noha Seif, OD, FAAO, FSLS; Dana Shannon, OD, FAAO; and Jennifer Tsai, OD. The research was commissioned by the Contact Lens Institute and conducted by Prodege from February 1-9, 2024, via an online survey. Respondents included 1,053 vision-corrected adults ages 18-64 residing in the United States. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
Contact Lens Institute & IACLE Collaborate to Bring Practice and Patient Insights to Contact Lens Educators
The Contact Lens Institute (CLI) and the International Association of Contact Lens Educators (IACLE) today announced a collaboration to provide university-level instructors with direct access to CLI-developed research publications and practice tools. Nearly 950 IACLE members—spanning more than 600 academic institutions and 81 countries—will be able to view and download CLI training and professional development materials from IACLETOP, the organization’s digital resource and teaching platform. These include multilingual assets for The EASY Way, CLI’s program to promote healthy contact lens wear-and-care, and in-depth consumer and practice management reports from CLI’s See Tomorrow initiative. “Putting Contact Lens Institute materials in the hands of contact lens educators around the globe allows them to be even more closely connected to relevant trends and insights from top clinicians. This will translate into better preparing tens of thousands of students entering the profession, who in turn can deliver better patient care and improved practice performance,” said Bonnie Boshart, chief executive officer of IACLE. Established in 1979, IACLE welcomes contact lens educators from all eye care professions and related disciplines. The non-profit organization is dedicated to raising the standard of contact lens education and promoting the safe use of contact lenses worldwide. It is the leading provider of educational and information resources essential to contact lens educators. For more information, visit iacle.org The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
CORE Publication Helps ECPs Prepare for New Wave of Dry Eye Disease Medications
In response to accelerating clinical interest about new, innovative treatments for dry eye disease, the Centre for Ocular Research & Education (CORE) has dedicated Issue 77 of Contact Lens Update to several recent introductions and promising pipeline developments. The publication is available at no charge by visiting ContactLensUpdate.com. “Dry eye disease affects millions of people across the world and can have a significant impact on their lives. Our growing understanding of this complex condition has led to the development of multiple new medications—both approved for sale and undergoing trials—that we believe have important clinical potential,” said Alex Hui, Head of Biosciences at CORE. “In primary eye care settings, dry eye is encountered daily. These additional treatments, targeting different aspects of the disease, will offer practitioners more options to incorporate into their prescribing arsenal and help patients better manage the condition.” Hui, who is also an adjunct associate professor at the School of Optometry and Vision Science, UNSW Sydney, shares his expertise in the issue’s editorial. His overview covers recently approved treatments such as a short-term corticosteroid to treat acute periods of worsened dry eye, a preservative-free ophthalmic solution that slows tear evaporation, and investigational products that either target inflammation or stimulate receptors on the ocular surface to increase the production of tears. The feature article is authored by Etty Bitton, a professor and director of the Externship Program and Dry Eye Clinic, School of Optometry, University of Montreal. She summarizes the findings of a systematic review and meta-analysis that investigated the efficacy and safety of a novel nasal spray to manage dry eye. Her article provides an overview of how different doses can impact signs of dry eye and reviews observed ocular and non-ocular adverse events. Quillan M. Austria, an ophthalmology resident at Weill Cornell Medical Center, New York Presbyterian Hospital, and Christopher Starr, an associate professor of ophthalmology and director of ophthalmic education at Weill Cornell Medical Center, co-author the issue’s clinical insight column. The case report details a patient’s experience with dry eye and management with a recently approved ophthalmic solution to treat Demodex blepharitis. The conference highlight is contributed by Alison Ng, a Lead Clinical Scientist at CORE, University of Waterloo. The abstract summarizes a presentation from the American Academy of Optometry 2023 annual meeting, detailing a phase two clinical trial that investigated the use of a new topical ointment to treat meibomian gland dysfunction. The work details changes in signs and symptoms over a three-month period of use. Published six times per year, Contact Lens Update provides a global platform for unbiased clinical insights based in current research. Since 2011, each issue has provided dependable and up-to-date ocular health information for more than 60,000 leading eye care professionals. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
Insights from Myopia Profile: Record Engagement & Impact Worldwide
Myopia Profile, the globally recognized clinical myopia management information center for eye care professionals (ECPs), today announced significant growth of traffic and engagement on its website, www.myopiaprofile.com. The 50% year-over-year increases signal widespread and accelerating interest in myopia etiology, prevention, interventions, and clinical practices. Innovative features and expanded functionalities were added to the site last year to offer more comprehensive product and scientific information. The subsequent surge in usage reflects continued interest in ECP demand for myopia resources and educational materials for their practices, further advancing the myopia management category and positive patient outcomes. “Revamping our website was a significant undertaking, and the payoff has been truly rewarding as we reviewed the year-end results,” said Dr. Kate Gifford, co-founder of Myopia Profile. “With over 200 countries seeking information on diverse topics in myopia and children’s vision care, it’s evident that there’s huge appetite for high quality and effective content. We’re delighted to offer invaluable and ever-expanding resources, aiding in the fight against the escalating myopia epidemic.” The top six countries accessing Myopia Profile’s free content were the United States, India, the United Kingdom, Australia, Canada, and Singapore, respectively. Users explored a diverse range of topics, encompassing axial length, myopia control spectacle lenses, contact lenses, and atropine; clinical techniques for children, and adult myopia management. Notably, the site’s new search feature and world-first Myopia Control Product Compendium revealed significant interest in spectacle lenses such as Stellest® and MiYOSMART, as well as for MiSight® 1 day myopia control contact lenses. Searches related to atropine also demonstrated substantial growth. In addition, Myopia Profile observed significant growth on www.mykidsvision.org, its consumer-facing website dedicated to providing parents with accessible, evidence-based information on myopia and its management at no cost. The platform aims to enhance awareness and education, with visitors soaring following extensive upgrades completed about 18 months ago. Here, orthokeratology and atropine emerged as the top-performing and fastest-growing search terms. Additionally, there has been a rise in searches regarding axial length and screen time, suggesting a transfer of prevention and care information from ECPs to caregivers. The three most popular topics were screen time, atropine eye drops, and spectacles. “We consistently engage with users to ensure we deliver the most relevant information tailored to their needs and practices,” said Dr. Gifford. “By listening to their feedback, in combination with keeping our eyes on the latest research, we can update our site with the most current information available. This ongoing process is rewarding because we understand that we are delivering precisely what ECPs need to assist their patients effectively.” To find out more about Myopia Profile and My Kids Vision, visit www.myopiaprofile.com and www.mykidsvision.org
-
EyeDocs of Rock Become the “Good Habits” in Support of New Contact Lens Institute Research
For more than 30 years, tens of thousands of music lovers from across the eye care and eyewear world have turned out to hear the Bad Habits—“The EyeDocs of Rock”—play in venues large and small. When the band kicked off its second set at the 2024 Vision Expo East opening event in New York, fans packing Sony Hall at the Paramount Hotel had to look twice: the group had suddenly rebranded itself as the Good Habits for one night only. This temporary name change resulted from a partnership with the Contact Lens Institute™ (CLI). The industry association is previewing new consumer research that shows how simple adjustments to how eye care practices communicate with patients can spark increased contact lens prescribing—bad habits made good. “As practicing optometrists, we couldn’t resist the chance to have some fun with this new CLI data, helping bring awareness to some intriguing insights that can benefit both patients and practices alike,” said bassist Michael “Jules” Raies, OD. Among the CLI findings were that significant untapped contact lens demand exists, with almost one in two (47.8%) U.S. glasses wearers who have never tried contacts saying they are highly interested. However, only one in 10 (10.5%) said their optometrist or ophthalmologist had recommended they consider contact lenses, with even lower rates from exam staff (6%), optical/eyewear display staff (3%), and administrative staff (2%) within the office. Adorned in jet black t-shirts with a custom Good Habits logo, the band launched into a song apropos for the moment: Lipps Inc.’s Funkytown and its signature “talk about it, talk about it, talk about it, talk about it” lyrics. As hundreds sang and danced along, the animated Good Habits logo twirled across the walls, encouraging everyone to visit GoodHabitsRock.com. The "Good Habits" at Sony Hall: keyboardist Dr. Bob Glass , guitarist Dr. Pat Dollenmayer, drummer Dr. Tony Fenton, bassist Dr. Michael “Jules” Raies, and keyboardist/guitarist Mark Schindler. CLI expects to publish its in-depth research report in April, part of its See Tomorrow initiative. Copies can obtained at no cost by visiting GoodHabitsRock.com or ContactLensInstitute.org The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org.
-
Research Shows Communications Adjustments Could Boost Contact Lens Adoption
Simple adjustments to how eye care practices communicate with patients may attract a significantly higher number of contact lens wearers, according to new data from the Contact Lens Institute (CLI). The industry association is previewing its latest See Tomorrow initiative consumer research at Vision Expo East this week, ahead of publishing an in-depth report next month. The findings reveal significant untapped contact lens demand, with almost one in two (47.8%) glasses wearers who have never tried contacts saying they are highly interested. However, only one in 10 (10.5%) said their optometrist or ophthalmologist had recommended they consider contact lenses, with even lower rates for exam staff (6%), optical/eyewear display staff (3%), and administrative staff (2%) within the office. “Our research has consistently shown that vision-corrected adults are waiting for their doctors to raise the possibility of contact lens wear—a straightforward action that enhances patient satisfaction and practice success,” said Stan Rogaski, CLI’s executive director. “This latest work delved even deeper into how that and other behaviors by practice teams play enormous roles in attracting or dissuading consumers from contemplating contact lenses and their many benefits.” More than half (51%) of glasses wearers said their lack of contact lens trial was directly influenced by in-practice behaviors or lack thereof. Specific detractors included not having been asked about contact lenses (20%), not being told they were a candidate (19%), and not being provided with contact lens information (18%). The same respondents were also asked to weigh 25 factors that would influence their consideration of contact lenses—all actions largely within the control of offices. Having their eye doctor explain why contact lenses would benefit the patient ranked first (66%), followed by understanding how to insert and remove lenses (52%), being given trial lenses at their appointment (51%), having a wide range of price and performance options (47%), and being aware of contacts for specific eye conditions (46%). While underlining that the entire practice team should communicate the advantages of contact lens wear, the CLI research highlighted that the optometrist or ophthalmologist must not completely delegate that responsibility. The influence of the aforementioned doctor’s recommendation (66%) is markedly more influential among patients than recommendations from exam staff (22%) and from eyewear display staff (8%). - Vision Expo East Events During Vision Expo East’s opening night event on Friday, March 15, CLI and the Bad Habits—the “EyeDocs of Rock”—will strike a unique musical partnership to bring added visibility to the latest research. Show attendees can present their badge for admission at Sony Hall at the Paramount Hotel Times Square, beginning at 9 p.m. ET. On Saturday, March 16, at 11 a.m. ET, several CLI Visionaries—eye care professionals who exemplify outstanding contact lens prescribing practices—will discuss the preliminary research findings on the Vision Expo East “The Bridge” main stage, sharing how they work with their teams to instill and reinforce behaviors that attract new contact lens wearers. “Beyond Vision: Behaviors to Supercharge Your Contact Lens Business” panelists include Jason Compton, OD, FAAO, Sabrina Gaan, OD, Scott Moscow, OD, and Adam Ramsey, OD, with moderation from Andrew Bruce, LDO, ABOM, NCLEM, FCLSA. “Opportunities to grow contact lens prescribing, with all the positives that brings to patient and practice, are substantial and well within reach of eye care offices. The Contact Lens Institute is excited to put this information into the hands of the eye care community, and offer ideas and insights for easy implementation,” said Rogaski. The research was commissioned by the Contact Lens Institute and conducted by Prodege from February 1-9, 2024, via an online survey. Respondents included 1,053 vision-corrected adults ages 18-64 residing in the United States. The sample size for glasses wearers who had never tried contact lenses was 579. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote, and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
Avalue Technology to Showcase Cutting-Edge Healthcare Solutions at HIMSS 2024
Avalue Technology will showcase its latest advancements in healthcare solutions at the upcoming HIMSS Global Health Conference & Exhibition, taking place at the McCormick Place Convention Center in Orlando, FL from March 12-14, 2024. Collaborating with its partners, Avalue will highlight innovative technologies tailored for smart hospitals, with a focuse on: l Embedded Motherboard for Medical Devices l 3D Displays Medical Panel PC / Open Frames l High Performance Computing for Medical Imaging l Medical Mobile Workstation Laptop Carts l Patient Information Solutions Over-bed Vitals Sensor l ePaper Patient Signs l LCD Patient Signs l Telehealth System To learn more about Avalue's offerings, please visit: https://www.avalue.com/public/HIMSS24/ At HIMSS24, Avalue will demonstrate its commitment to streamlining healthcare workflows and providing smarter solutions. One of the key showcases will be the VI-SOR Smart Operating Room Dashboard Solution, in partnership with AUO Display Plus. This innovative solution, paired with the Avalue MAB-T600, enables visualization for streamlined workflows with a unified data dashboard, surgical lists and records, real-time video streaming, and plug-and-play integration. In addition, the 3D imaging solution for remote surgical training features a 32-inch 4K 3D medical display capable of streaming 3D images for robotic and minimally invasive surgeries. The Over-bed Vitals Sensor, integrated into the SmartCaring T60 improves patient care in hospitals and long-term care facilities. Offering contactless monitoring, this solution ensures safety by utilizing millimeter wave and thermal sensors to track vital signs including breathing, heart rate, temperature, and activity. With Azure Sphere and cloud technology, personalized care delivery is enabled, prioritizing patient comfort and privacy while reducing infection risks and aiding in early detection of deterioration without burdening staff. Avalue's smart ward solution includes ePaper displays for 42” communication boards and 25” digital signage, patient infotainment, and ePaper/LCD patient signs. These solutions are designed to keep patients informed and involved in their healthcare journey, prioritizing communication throughout the care process. Another area of focus is the telehealth system, with Avalue offering powerful portable batteries medical cart to ensure uninterrupted medical care, along with AVer medical-grade PTZ cameras with AI functions designed for patient monitoring. The Medical Mobile Workstation Laptop Carts, designed to fit most laptops/notebooks, provide ample space and easy usability. Avalue looks forward to meeting with attendees at HIMSS24. To explore these innovative smart hospital solutions, please visit Avalue and its partners at booth #4681. For more information on Avalue solutions and the HIMSS24 showcase, please visit Avalue's website at https://www.avalue.com/en or contact our sales team at sales@avalue-usa.com
-
Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights
Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update. Published by the Centre for Ocular Research & Education (CORE), the bi-monthly publication is available at no charge by visiting ContactLensUpdate.com. “Specialty lenses play a vital role in addressing diverse visual needs and managing myopia. Keeping abreast of the latest research is essential for evidence-based practice, ensuring that patients receive optimal care aligned with current understanding,” said Daddi Fadel, DOptom, FSLS, FBCLA, FAAO, FIACLE, a clinical scientist at CORE and author of the issue’s opening editorial. “By integrating insights from different fields and staying informed about emerging techniques and technologies, practitioners can achieve successful lens fittings that address immediate concerns and contribute to long-term ocular health preservation. Interdisciplinary collaboration further enhances the effectiveness of treatment plans, allowing for a comprehensive approach that considers various aspects of ocular health and—paramount to provide customized care that meets each patient's unique needs.” Dr. Fadel is a pioneer of modern lens designs, editor-in-chief of the Journal of Contact Lens Research & Science, and author of several peer-reviewed articles and books. Her editorial presents comprehensive highlights from the 2024 Global Specialty Lens Symposium (GSLS). These include discussions on the inflammatory nature of contact lens wear, the Ed Bennett-Nathan Efron debate concerning the viability of rigid lenses, masterclasses and workshops on scleral lenses and myopia management, and emerging technologies presentations. Sharon Qiu is a residency-trained optometrist pursuing a full-time Ph.D. in Vision Science at CORE while also serving as a part-time clinical supervisor for 4th-year optometry interns at the University of Waterloo Contact Lens and Myopia Control Clinic. She authors the feature article that explores techniques for practitioners to evaluate the performance of scleral lenses, and the instruments that are most suitable for this purpose. Greg DeNaeyer, an optometrist at Arena Eye Surgeons in Delaware, Ohio, with an emphasis on specialty contact lenses and a contributor to several professional publications, shares his expertise in the form of a clinical insight. The article reviews three of the most common scleral lens fitting complications—poor wettability, midday fogging, and corneal edema—and suggests methods to enhance the process and performance, such as using modern materials, coatings, and alternative treatments. The conference highlight is shared by David Hammond, a researcher specializing in myopia control at CooperVision's Advanced Development Center in Pleasanton, Calif. His award-winning poster examined MiSight 1 day's effectiveness in controlling myopia progression over six years, comparing progression between control and treatment cohorts, including a group whose treatment was initiated in year four. The study found that MiSight 1 day effectively controlled myopia progression, especially benefiting faster-progressing eyes, with consistent proportional treatment effects that contradict predictions of a random growth model. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by the International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
Contact Lens Institute Reboots "EASY Does It" Video Series
Several prominent members of the U.S. and Canadian eye care community are voicing their support for The EASY Way, the Contact Lens Institute’s (CLI) initiative to help promote healthy, comfortable contact lens wear and care behaviors. CLI has rebooted its popular “EASY Does It” one-minute video series, in which optometrists, opticians, and staff describe one way their colleagues can better reach patients through conversations that take only seconds. 2024 CLI Visionaries including Monica Bhula, OD, Jenn Seymour Brusven, LDO, Janelle Davison, OD, Scott Moscow, OD, Shalu Pal, OD, and Adam Ramsey, OD, are featured in new episodes, with additional segments planned throughout the coming weeks. All “EASY Does It” videos are available as a YouTube playlist at bit.ly/EASYDoesIt. Now in its fourth year, The EASY Way (Eyes, Awareness, Safety and You) has been adopted by eye care practices across the U.S., Canada, and worldwide. It includes simplified tips, attention-grabbing infographics, and companion digital resources for use in practices, presented in a memorable and straightforward way. All components are available for free download within The EASY Way resource page on ContactLensInstitute.org. At the center of the program are three easy steps: 1. Think Clean. Wash and dry your hands every time before touching your lenses or eyes. If you wear reusable lenses, always clean and disinfect them with each removal, and clean your lens case as directed. Keep your lenses and case away from any type of water, which can contain harmful microorganisms. 2. Remember Fresher is Better. Wear your contacts for only as long as your eye care professional says, replacing them with fresh lenses on schedule. Only wear daily disposable lenses once, and always rely on new solution for reusable lens disinfection and storage. Replace your lens case at least every three months. 3. Trust Your Eye Doctor. Listen to your eye care professional, who has specialized training. If you have any questions, contact their office—they care about your health and great vision. The rebooted “EASY Does It” video series is being promoted across CLI’s social media channels, CLI Visionaries’ personal and practice digital channels, and through CLI member companies Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. The Contact Lens Institute advances the latest innovations in safe and effective contact lens and lens care products and services that provide unique benefits to patients while satisfying the evolving needs of eye care professionals. CLI undertakes activities that properly assess, enhance, promote and balance contact lens and lens care industry welfare and growth, including the safe use of products in the marketplace. Its members include Alcon, Bausch + Lomb, CooperVision, and Johnson & Johnson Vision. For more information, visit contactlensinstitute.org
-
SightGlass Vision Receives FDA Breakthrough Device Designation
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its Diffusion Optics Technology™ (DOT™) spectacle lenses, which are intended to slow myopia progression in children. The unique design is the first to use the contrast management mechanism of action, incorporating thousands of elements that gently scatter light across the retina. The FDA’s Breakthrough Devices Program is for highly innovative devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions. Manufacturers are given more frequent opportunities for FDA feedback during the premarket review phase, as well as a prioritized submission review. Since the program’s introduction in 2015, only 18 other ophthalmic devices have received the Breakthrough Device designation.* “The FDA Breakthrough Device designation for Diffusion Optics Technology™ (DOT™) spectacle lenses is a milestone for our organization—and for the broader fight against the pediatric myopia epidemic. Recent studies1,2 illustrate that about half of U.S. children are myopic, yet most are not receiving treatments proven to slow myopia progression,” said Andrew Sedgwick, CEO of SightGlass Vision. “We are enthusiastic about more closely collaborating with the FDA as we pursue U.S. market clearance.” SightGlass Vision’s patent-protected technology has demonstrated proven efficacy and safety through rigorous clinical evaluation.3,4,5,6 As reported in September 2023, full four-year outcomes from the pivotal CYPRESS study showed statistically significant slowing of axial length progression and cycloplegic spherical equivalent refraction.7 Diffusion Optics Technology™ (DOT™) spectacle lenses have made their commercial debut in several markets, including China, the Netherlands, and Israel, as well as through preliminary market trials in other countries. For more information, visit SightGlassVision.com
-
Paw-sitive reception for robot guide dog could lead to new assistive technologies
Blind and partially sighted people could soon receive help to find their way around indoor spaces from chatty robot guide dogs currently in development at a Scottish university. Experts from the University of Glasgow have partnered with industry and two leading charities to develop the RoboGuide, an AI-powered four-legged robot which aims to help visually impaired people move more independently through museums, shopping centres, hospitals and other public places in the future. The RoboGuide prototype integrates a range of cutting-edge technologies into an off-the-shelf robot body to help overcome the challenges preventing robots from being more widely used to assist blind and partially sighted people. The project aims to bring a more complete version of the technology to market in the years to come to help support the 2.2 billion people around the world, and two million people in the UK, who live with sight loss. Prof Muhammad Imran, Dean of graduate studies at the University of Glasgow’s James Watt School of Engineering, is co-investigator on the project. He said:” Our assistive technology project for the visually impaired embodies innovation, fostering inclusivity. In Glasgow, we're pioneering world-changing technologies that hold the potential to transform lives and reshape societal norms. This achievement was made possible through collaboration with industry and charity partners and co-creating the design with the invaluable input of end users.” Dr Olaoluwa Popoola, of the University of Glasgow’s James Watt School of Engineering, is the RoboGuide project’s principal investigator. He said: “Assistive technologies like the RoboGuide have the potential to provide blind and partially sighted people with more independence in their daily lives in the years to come. “One significant drawback of many current four-legged, two-legged and wheeled robots is that the technology which allows them to find their way around can limit their usefulness as assistants for the visually impaired. “Robots which use GPS to navigate, for example, can perform well outdoors, but often struggle in indoor settings, where signal coverage can weaken. Others, which use cameras to ‘see’, are limited by line of sight, which makes it harder for them to safely guide people around objects or around bends.” The RoboGuide system uses a series of sophisticated sensors mounted on the robot’s exterior to accurately map and assess its surroundings. Software developed by the team help it learn the optimal routes between locations and interpret the sensor data in real-time to help the robot avoid the many moving obstacles it might encounter while guiding a human. The RoboGuide also incorporates large language model technology, lending it the ability to understand questions and comments from users and provide verbal responses in return. The Forth Valley Sensory Centre (FVSC) Trust (FVSC) and the Royal National Institute of Blind People (RNIB) Scotland have lent their support to the development of the RoboGuide. In December, the RoboGuide was tested for the first time with volunteers from FVSC and RNIB at the Hunterian, Scotland’s oldest museum. The RoboGuide helped the volunteers find their way around the first floor of the museum, and provided interactive spoken guidance on six exhibits. Dr Wasim Ahmad, of the James Watt School of Engineering, is co-investigator on the project. He said: “We’re pleased to be working closely with the FVSC and RNIB Scotland to test the RoboGuide in real-world environments, and to integrate their feedback into more refined iterations of the technology. “Ultimately, our aim is to develop a complete system which can be adapted for use with robots of all shapes and sizes to help blind and partially sighted people in a wide range of indoor situations. We hope that we can create a robust commercial product which can support the visually impaired wherever they might want extra help.” Representatives from the Forth Valley Sensory Centre and RNIB Scotland are joining the Glasgow research team at the University of Glasgow’s Mazumdar-Shaw Advanced Research Centre today (Thursday 8 February) for an event showcasing the ongoing development of the RoboGuide. Jacquie Winning MBE, the chief executive of the Forth Valley Sensory Centre, said: “Mobility is a big issue for the blind and partially sighted community. RoboGuide is a wonderful solution to that problem, and we are delighted to help test this innovative and creative robot. “We are pleased to play our part in helping to harness the power of new technology to improve the independence and confidence of people with sensory loss and make sure they can live their lives to the full.” James Adams, Director, RNIB Scotland, says, “We're delighted to be supporting the research and development of technology that could be part of making the world more accessible and empowering blind and partially sighted people to live their lives confidently. “Technology innovations like this are reshaping the future of accessibility and this partnership demonstrates their burgeoning potential to create of a more inclusive world.” The nine-month research project is supported by funding from the Engineering and Physical Sciences Research Council (EPSRC), part of UKRI, through the Impact Acceleration Account programme.
-
Avalue to Exhibit at Arab Health 2024 to Facilitate Accuracy and Smooth Workflow in Healthcare
Avalue Technology Inc. (TAIEX: 3479-TW), a global industrial PC solution provider and a Titanium member of the Intel® Internet of Things Solutions Alliance, endeavors to provide a complete range of smart retail, smart healthcare, smart manufacturing, smart transportation and embedded solutions. Avalue Technology will exhibit in the Arab Health 2024 to optimize the workflow in healthcare in January 29 to February 1, 2024. We are aware of the urgency for changing existing workflow in modern hospital, here we demonstrate solutions including: l Hybrid OR l Medical HMI Application l Smart Ward Solution l Embedded Computer Module and Computing Platform The Hybrid Operating Room (OR) revolutionizes surgery by seamlessly integrating preoperative, intraoperative, and postoperative imaging. This advanced facility ensures synchronized imaging and surgical precision, optimizing patient outcomes. With high-definition visuals and essential components like the multi-viewer and Avalue medical grade touchscreen monitor along with the medical certification ready expandable box system powered by 12/13th Generation Intel® Core™ Processors, the Hybrid OR transforms surgical care standards through technology and expertise. In the face of healthcare workforce shortages and the complexities of modern healthcare, Avalue's Medical HMI stands out as a pivotal solution. Our semi-rugged tablets compatible with Android 11 and Windows 10, and 15-inch medical-grade touchscreen panel PC equipped with the 12th Generation Intel® Core™ processor, catering to diverse usage scenarios, this innovative approach addresses these challenges by digitizing workflows, ensuring quick access to critical information, and significantly reducing reliance on cumbersome paperwork. This fosters a new era of efficiency, enabling healthcare providers to prioritize optimal patient care. Hospitals often struggle with integrating technology into patient care, emphasizing hardware like computers and tablets. Yet, the oversight of software presents challenges in healthcare management. Avalue's Smart Ward Solution addresses this by redefining the paradigm, offering an ePaper healthcare display with no blue light emission to efficiently handle information dissemination. Moreover, a bedside Panel PC utilizing the Rockchip platform, featuring a lightbar, handset phone, and infotainment software, our solution optimizes patient-doctor communication, transforming healthcare management into a seamless, patient-centric experience. Avalue’s computing platform for motherboards and systems offers tailored design, manufacturing, and integration services, providing clients competitive solutions in cost-effectiveness. Addresses diverse needs and constraints, ensuring adaptability beyond standard configurations. Additionally, we provide an open-frame architecture suitable for the rapid deployment and iterative updates suits for medical equipment, along with a variety of system peripherals. Leveraging Avalue's extensive ODM/OEM capabilities and substantial experience in medical certifications, we deliver seamless and efficient solutions to address various challenges for our clients. Avalue prioritizes enhanced connectivity, facilitating real-time data exchange for informed decision-making. With an emphasis on patient-centricity, it provides a platform for personalized care. Visit Avalue at Booth #SA.A39, and experience it for yourself! Visit www.avalue.com for more information, or contact sales@avalue.com.tw to talk to our sales team.
-
New HealthScribe & Conference Captioning Free Apps for the Deaf Community at CES 2024
BeAware https://www.deafassistant.com/, creator of the free fastest transcription app for the Deaf and hard of hearing, announced today that it will launch a new line of free fast, accurate apps for the Deaf and hard-of-hearing community at CES 2024: the BeAware Conference Captioning App and HealthScribe app, designed to make the world easier and safer for Deaf people and the only specialized Deaf assistant apps designed with easy communication and safety in mind. Conference Captioning App Only Tool for Real-time Captioning for In-Person Events The BeAware Conference Captioning app is the only tool that provides the Deaf and hard of hearing quick accessibility to any in-person event within 15 seconds for real-time captioning for speeches, live events, press conferences, and trade shows. Based on the popular BeAware d/Deaf Assistant app, the top 50 medical app in 13 countries and currently in use in over 50 countries and 30+ languages, speakers and event organizers can easily capture live transcriptions allowing Deaf attendees to stream captions in real-time on their smartphones, ensuring an inclusive experience for all participants -- especially important for emergency press conferences and alerts. For developers, the BeAware Conference Captioning App Enterprise version is also available with API access to integrate their apps with BeAware, along with accessibility for live translations into 30+ languages. Key markets for the BeAware Conference Captioning app include healthcare, government, first responders, and hospitality industries. See the BeAware video at: https://vimeo.com/838702172 HealthScribe Offline Private Live Transcriptions for the Deaf & Translations for Limited English Proficiency Patients HealthScribe is an essential tool used in hospital emergency rooms to provide offline fast privacy-safe live transcriptions for Deaf and hard-of-hearing patients, as well as translations for patients with limited English proficiency (LEP). Live transcriptions and live translations are available while the patient is 100% offline without storing the user's data of personal information, making it the perfect companion for geriatric hospitals and medical institutions with a diverse patient language base. Implemented and licensed specifically for each hospital and free for patients, the solution is paid by hospitals depending on the implementation scale, number of languages, and whether managed devices are required. HealthScribe is AgeTech that helps older people with hearing loss become much more confident at the doctor's office and is also available after a free trial at $100/month for doctors to purchase directly. Reducing Inequalities: Part of the 10th UN Sustainable Development Goal Focused on reducing inequalities as part of the 10th UN Sustainable Development Goal, BeAware helps organizations and governments support their commitment to accessibility by providing dedicated streams with blazing-fast accuracy. An example of BeAware’s real-time live translations was seen at the recent Michigan's Build Institue entrepreneurial support institute, which showcased the ability to use BeAware’s technology, even without the need to download the app. According to the World Health Organization, there are 430 million people worldwide who identify as hard-of-hearing or Deaf, or 1 person in every 3 households in every neighborhood in every country. Learning to read lips is not enough for safety. With BeAware, the app reads text aloud during live phone calls and more, assisted by customizable preset phrases. BeAware even provides visual LED flashes and sensory alert vibrations through smartwatches and smartphones and users can customize alerts, so if a baby is crying, a deaf mom can get a vibration through a push notification, along with an LED flash; or if a hard-of-hearing delivery driver is pulled over, the driver can use the app to transcribe what a police officer is saying and can even communicate with the officer, without having to use sign language. “I was tired of seeing all the apps that charge $100/year for essential everyday tools needed by the Deaf,” said Saamer Mansoor, Founder & CEO, BeAware. “So four friends and I joined together to make a difference and do something about it. The result was BeAware. We developed the app for the Deaf and optimized it to make it the best possible experience.” BeAware Features: Alerts: only app that allows the user to turn the phone around into an elite alerting tool with customizable alerts of short or prolonged sounds. Converts speech to text. Text: only app that can read text aloud during live phone calls, assisted by customizable preset phrases. Fastest transcription speeds. While in person: flips text, stores preset phrases, and changes font size for easier reading. Remotely: plays typed text during audio and video calls. Converts ambient noise to visual and haptic alerts. Free for life. Works on iOS (iPhones and Apple watches) and Android. Works in 30+ languages. Works while the app is in the background. Works 100% off-grid. BeAware at CES 2024 & Availability BeAware will be at CES 2024, Booth #60464 at the Venetian Expo, Eureka Park, Level 1, Hall G. The BeAware apps will be demoed through a hearing experiment, where consenting booth visitors wear earplugs and try to communicate with a hearing person and then communicate with the app. For more information, see the websites: https://conferencecaptioning.com/, https://medicalsubtitles.com/, and https://www.deafassistant.com/
-
CORE Explores Presbyopia Pharmacological Treatments in New Publication
Even with recent advances, managing presbyopia still presents significant challenges for achieving perfect vision at all distances. The Centre for Ocular Research & Education (CORE) has focused Issue 75 of Contact Lens Update to exploring current and future pharmacological treatments, and how they compare to multifocal contact lenses. The independent, bi-monthly publication is available at no charge by visiting ContactLensUpdate.com. “Understanding the treatment strategies for presbyopia is essential. Since there is no universally perfect solution, success lies in selecting and customizing the appropriate treatment for each individual patient,” said Daddi Fadel, DOptom, FSLS, FBCLA, FAAO, FIACLE, a clinical scientist at CORE. “Advancements in pharmacological treatments have led to various ophthalmic solutions, with additional options currently under investigation. Integrating therapeutics into the array of management strategies may provide practitioners and patients with broader choices for effective treatment.” Optimal presbyopia management outcomes, with the goal of ensuring the best visual performance at all distances, hinge on understanding the advantages and limitations of each option in accordance with patient needs and ocular conditions. As pharmacological treatments progress, it remains crucial for eye care practitioners to incorporate these management strategies in their arsenal and remain abreast of the latest developments to offer personalized solutions. Leading off the Diamond Jubilee issue are Dr. Elisabeth Van Aken, an ophthalmologist, retina specialist and assistant professor at Ghent University, Belgium, alongside Dr. Joris Delanghe, professor in Clinical Chemistry at Ghent University, Belgium and editor-in-chief of Clinica Chimica Acta. Their opening editorial comprehensively reviews pharmacological treatments for presbyopia, providing a detailed summary of the current solutions available. Dr. Selina McGee, founder of Precision Vision of Edmond and co-founder of Precision Vision of Midwest City, specializes in dry eye, contact lenses, and aesthetics, and holds an adjunct faculty position at Northeastern State University College of Optometry. Her feature article reviews existing therapeutic drops and those in clinical trials, evaluating their potential for significant improvements in near and intermediate vision. Dr. Jacob Lang, chair of the Anterior Segment Section at the American Academy of Optometry and frequent ophthalmic publications contributor, is joined by Dr. Noa Robson, an ocular disease resident at Associated Eye Care in Stillwater, Minn. to author the issue’s clinical insight. Their case report underscores the importance of listening to each patient’s needs, consider the ocular surface, and explore diverse options to determine the optimal individualized treatment. The conference highlight is presented by Dr. Shane Kannarr, a specialist in contact lenses, ocular disease treatment, and low vision. His featured poster evaluates reading performance and associated satisfaction in mild presbyopia treated with 1.25% pilocarpine hydrochloride ophthalmic solution. The findings indicate improved visual outcomes with the drug compared to the vehicle. In addition to a complete archive of back issues, ContactLensUpdate.com offers a resource library that provides no-cost professional tools, patient resources, images and video. It also houses complimentary technical training videos produced by International Association of Contact Lens Educators, plus an industry glossary. Industry professionals can access the latest issue directly from ContactLensUpdate.com or quickly sign up for email receipt of future issues. The publication receives support from the educational arms of Alcon, CooperVision, and Johnson & Johnson Vision.
-
My Kids Vision: Strides in Community Impact and Exponential Growth in 2023
Myopia Profile, the internationally trusted clinical myopia management information center for eye care professionals (ECPs), concludes 2023 by celebrating the significant community impact of its My Kids Vision (www.mykidsvision.org) website. This free resource for parents, which provides easy-to-digest, evidence-based information on myopia and its management, has measurably heightened awareness and education, particularly following substantial platform upgrades in 2022. “Our motivation behind revamping My Kids Vision was to streamline the communication of the entire myopia message, recognizing that the intricacies involved could be a barrier to effective myopia management,” said Dr. Kate Gifford, co-founder of Myopia Profile. “Since the site’s relaunch, we’ve experienced an impressive 160% surge in pageviews, indicating an increase in parents and caregivers turning to our platform for informed decision-making regarding the vision health of their children.” Newly reported for 2023, ECPs across 194 countries regularly access My Kids Vision as an invaluable resource in guiding parents through their child’s myopia management journey. The platform experienced major global growth, with a 170% increase in the U.S., 155% in the U.K., and 165% in Canada. This widespread adoption is noteworthy as it ensures that an expanding number of countries, through access to the site’s Knowledge Center, are benefitting from over 50 articles explaining myopia, treatment options, and children’s vision. This growth not only emphasizes the global reach of My Kids Vision but also facilitates interventions that can optimize the vision and eye health outcomes of children with myopia well into their adult lives. “Leveraging the My Kids Vision website is invaluable for patient education at my practice. Instructional videos, especially on the art of contact lens handling, save time and positively impact patient and parent readiness for discussions on myopia management,” said Dr. Heidi Hunter, optometrist and managing director at Custom Eyecare, Newcastle, Australia. “The site provides clarity, professionalism, and expert insights and serves as a guiding light, offering much-needed information, reassurance, and empowerment for informed decisions about children’s eye health,” said Dr. David Kading, optometrist at Specialty Eye, Seattle, Washington. Several key features of My Kids Vision are currently available in seven languages. Additional languages for the Knowledge Center and other content are in development. For more information, visit www.mykidvision.org
